JP2012531612A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012531612A5 JP2012531612A5 JP2012518798A JP2012518798A JP2012531612A5 JP 2012531612 A5 JP2012531612 A5 JP 2012531612A5 JP 2012518798 A JP2012518798 A JP 2012518798A JP 2012518798 A JP2012518798 A JP 2012518798A JP 2012531612 A5 JP2012531612 A5 JP 2012531612A5
- Authority
- JP
- Japan
- Prior art keywords
- macro
- cancer
- expression
- patient
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09008679.4 | 2009-07-02 | ||
| EP09008679A EP2270510A1 (en) | 2009-07-02 | 2009-07-02 | Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms |
| PCT/EP2010/004008 WO2011000573A1 (en) | 2009-07-02 | 2010-07-02 | Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoforms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012531612A JP2012531612A (ja) | 2012-12-10 |
| JP2012531612A5 true JP2012531612A5 (enExample) | 2013-08-08 |
| JP5792165B2 JP5792165B2 (ja) | 2015-10-07 |
Family
ID=41100520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012518798A Expired - Fee Related JP5792165B2 (ja) | 2009-07-02 | 2010-07-02 | ヒストンマクロｈ２ａアイソフォームに基づいて癌再発のリスクを予測する診断のための判断材料を提供する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120171225A1 (enExample) |
| EP (2) | EP2270510A1 (enExample) |
| JP (1) | JP5792165B2 (enExample) |
| CN (1) | CN102472753B (enExample) |
| AU (1) | AU2010268389B2 (enExample) |
| BR (1) | BRPI1011925A2 (enExample) |
| CA (1) | CA2766656A1 (enExample) |
| ES (1) | ES2681687T3 (enExample) |
| SG (1) | SG177398A1 (enExample) |
| WO (1) | WO2011000573A1 (enExample) |
| ZA (1) | ZA201109381B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201115098D0 (en) * | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| GB201604806D0 (en) * | 2016-03-22 | 2016-05-04 | Singapore Volition Pte Ltd | Method of identifying a cancer of unknown origin |
| EP3508855A1 (en) * | 2018-01-05 | 2019-07-10 | Allianz Pharmascience Ltd | Method for the selection of patients and kit |
| EP3546944A1 (en) * | 2018-03-30 | 2019-10-02 | Universite d'Aix-Marseille (AMU) | Diagnosis and treatment of a cancer based on the overexpression of the adamtsl5 gene |
| CN108957004B (zh) * | 2018-07-09 | 2021-10-19 | 东南大学 | 检测H3K9me2和H3K36me3表达量的试剂在制备胃癌预后评估试剂盒中的应用 |
| CN111896740B (zh) * | 2019-05-06 | 2025-02-11 | 山东大学 | 诊断或预测生育缺陷的试剂盒 |
| CN119736252B (zh) * | 2025-01-15 | 2025-06-27 | 首都医科大学 | 组蛋白变体macroH2A调控巨噬细胞功能在改善肿瘤免疫微环境中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2197915B (en) | 1986-11-19 | 1990-11-14 | Rolls Royce Plc | Improvements in or relating to fluid bearings |
| US20020052308A1 (en) * | 1999-03-12 | 2002-05-02 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
| US20030190640A1 (en) * | 2001-05-31 | 2003-10-09 | Mary Faris | Genes expressed in prostate cancer |
| US20030124579A1 (en) * | 2001-09-05 | 2003-07-03 | Eos Biotechnology, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| JP4155464B2 (ja) * | 2002-01-31 | 2008-09-24 | 独立行政法人科学技術振興機構 | 抗ヒトｃｅｎｐ−ａペプチドモノクローナル抗体産生ハイブリドーマ細胞の作成、及びその利用法 |
| DK1388734T3 (da) * | 2002-08-01 | 2004-05-03 | Mtm Lab Ag | Metode til opløsningsbaseret diagnose |
| CN100480382C (zh) * | 2002-08-16 | 2009-04-22 | 抗癌公司 | 实时测量细胞反应 |
| US20050181375A1 (en) * | 2003-01-10 | 2005-08-18 | Natasha Aziz | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer |
| KR20060013426A (ko) * | 2003-05-30 | 2006-02-09 | 니뽄 신야쿠 가부시키가이샤 | Ｂｃｌ-2의 발현을 억제하는 올리고 이중쇄 ＲＮＡ와그것을 함유하는 의약 조성물 |
| US20070148648A1 (en) * | 2003-11-04 | 2007-06-28 | Martin Dugas | Method for distinguishing who classified aml subtypes |
| DE102004037860A1 (de) * | 2004-08-04 | 2006-03-16 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen |
| WO2006119435A2 (en) * | 2005-05-04 | 2006-11-09 | Invitrogen Corporation | Identification of cancer biomarkers and phosphorylated proteins |
| WO2006138275A2 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US9150628B2 (en) * | 2005-11-14 | 2015-10-06 | Centre National De La Recherche Scientifique (Cnrs) | PARP inhibitors |
| US8492328B2 (en) * | 2007-05-17 | 2013-07-23 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
| JP2008292424A (ja) * | 2007-05-28 | 2008-12-04 | Nippon Medical School | 腫瘍の検出方法 |
| BRPI0815460A2 (pt) * | 2007-09-07 | 2019-02-26 | Univ Bruxelles | kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos |
| WO2009146545A1 (en) * | 2008-06-05 | 2009-12-10 | University Health Network | Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
-
2009
- 2009-07-02 EP EP09008679A patent/EP2270510A1/en not_active Withdrawn
-
2010
- 2010-07-02 BR BRPI1011925A patent/BRPI1011925A2/pt not_active Application Discontinuation
- 2010-07-02 JP JP2012518798A patent/JP5792165B2/ja not_active Expired - Fee Related
- 2010-07-02 SG SG2011096849A patent/SG177398A1/en unknown
- 2010-07-02 AU AU2010268389A patent/AU2010268389B2/en not_active Ceased
- 2010-07-02 ES ES10730098.0T patent/ES2681687T3/es active Active
- 2010-07-02 CA CA2766656A patent/CA2766656A1/en not_active Abandoned
- 2010-07-02 US US13/380,324 patent/US20120171225A1/en not_active Abandoned
- 2010-07-02 WO PCT/EP2010/004008 patent/WO2011000573A1/en not_active Ceased
- 2010-07-02 CN CN201080029880.5A patent/CN102472753B/zh not_active Expired - Fee Related
- 2010-07-02 EP EP10730098.0A patent/EP2449383B1/en not_active Not-in-force
-
2011
- 2011-12-20 ZA ZA2011/09381A patent/ZA201109381B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220334128A1 (en) | Method for the enrichment of circulating tumor dna | |
| Mocan et al. | Liquid biopsies in hepatocellular carcinoma: are we winning? | |
| Cheng et al. | Diagnostic value of different phenotype circulating tumor cells in hepatocellular carcinoma | |
| Lee et al. | Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC) | |
| JP2012531612A5 (enExample) | ||
| Li et al. | Current status of ctDNA in precision oncology for hepatocellular carcinoma | |
| Ziol et al. | ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma | |
| Ghazani et al. | Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance | |
| Wang et al. | Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma | |
| Santos et al. | Liquid biopsy: The value of different bodily fluids | |
| Block et al. | The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop | |
| JP2017520763A5 (enExample) | ||
| Black et al. | The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome | |
| Goggins | Markers of pancreatic cancer: working toward early detection | |
| Kim et al. | Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma | |
| Liu et al. | Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients | |
| CN102472753B (zh) | 基于组蛋白macroH2A同工型预测癌症复发风险的诊断方法 | |
| KR20190013707A (ko) | 암 검출을 위한 뉴클레오솜-전사 인자 복합체의 용도 | |
| CA2623653A1 (en) | Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis | |
| Seo et al. | Epidemiologic study of human epidermal growth factor receptor 2 expression in advanced/metastatic gastric cancer: an assessment of human epidermal growth factor receptor 2 status in tumor tissue samples of gastric and gastro-esophageal junction cancer | |
| JP2021019612A (ja) | 治療剤に対する抵抗性の診断に使用するためのＥＲＣＣ１アイソフォーム３のｍＲＮＡおよび／またはタンパク質ならびにこのｍＲＮＡおよび／またはタンパク質を使用する治療剤に対する抵抗性を診断するための方法 | |
| CN103562722A (zh) | 一种区分甲状腺癌变的方法、实施该方法的试剂盒以及金属硫蛋白在区分甲状腺癌变中的用途 | |
| Wang et al. | Use of cytokeratin-19 concentration to assess early recurrence and prognosis of hepatitis B virus-related hepatocellular carcinoma following radical resection in patients with a low serum alpha-fetoprotein concentration | |
| JP2010216826A (ja) | 新規腫瘍マーカーを用いた乳癌の検査方法 | |
| Rutkowska-Kawalec et al. | Liquid biopsy-a review |